Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

Valantine Hannah bought $44,476 worth of shares (3,433 units at $12.96) (SEC Form 5)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.

Valantine Hannah bought $44,476 worth of shares (3,433 units at $12.96) (SEC Form 5) | Quantisnow